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ABSTRACT 
A novel approach of using near infrared region (NIR) dyes is applied to elucidate the binding 
interaction between human serum albumin (HSA) and mangiferin (MGF). HSA is a blood carrier 
protein used for drug delivery, while mangiferin is a natural polyphenol found in mangoes that 
possesses numerous beneficial health properties. The NIR dyes are used as a probe to investigate 
MGF binding interaction with HSA via monitoring fluorescence of Trp-214 residue. Molecular 
modeling is used for docking and semi-empirical analysis. The investigation of the binding 
interaction between Trp-214 and MGF is significant, for it may offer broader pharmacological 
insight and applications for the polyphenol. Mangiferin in proposed to bind with a 2:1 
stoichiometric ratio with HSA to the Trp-214 residue in subdomain IIA and another possible 
binding site to be determined in future studies. Spectral changes suggest a stabilized protein 
conformation upon mangiferin binding with the addition of NIR dye E-06 and MHI-06.   
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1 INTRODUCTION 
1.1 Mangifera indica L. 
 Mangifera indica L., more commonly known as the fruiting mango tree, is rich in various 
therapeutic compounds. The most abundant compound making up 10% of the stem bark and 
roughly 42% of dry mango peel weight is mangiferin (2-β-D-glucopyranosyl-1,3,6,7-
tetrahydroxy-9H-xanthen-9-one).[2] Mangiferin (MGF) is a polyphenol glucosylxanthone and 
may also be obtained from the honey bush and other sources. 
The clinical applications of Mangiferin include treatment of 
allergies, dysentery, scabies, infection, inflammation, cancer, 
viral infections and as a vermifuge[3]. Mangiferin has also 
been found to chelate iron[2, 3b, 4]. 
 Considering mangiferin’s versatility and broad range 
of therapeutic potential, the mechanism behind its 
pharmacological behavior is of great interest. Elucidation of 
the interactions between MGF and macromolecules may provide insight as to the how the 
numerous therapeutic benefits from MGF may be maximized, allowing for advances in 
pharmacy and health care. 
 The macromolecule selected for binding analysis is human serum albumin. This is the 
most abundant protein in the human body and also a carrier protein, which participates in drug 
distribution and delivery. Thus, the mangiferin must come into contact with the albumin during 
transport. Previous literature has proposed that MGF binds to the hydrophobic binding cavity 
within subdomain IIA to the Trp-214 residue[5]. This Trp-214 residue is the only tryptophan in 
Fresh mangoes rich in 
mangiferin purchased from the 
local Dekalb Farmers Market.   
Figure 1. Mangifera indica L.	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the entire macromolecule and is responsible for protein fluorescence. Thus, absorbance and 
fluorescence spectroscopy will be applied in order to investigate the binding interaction between 
human serum albumin and MGF. Spectroscopic analysis was accompanied by molecular 
modeling to examine the mangiferin ligand binding to the Trp-214 receptor.  Similar 
investigations have been previously performed with a spectrophotometric focus on the binding 
ligand rather than the fluorescent tryptophan residue itself. This study will specifically focus on 
the binding interactions from the perspective of the Trp-214 residue.  
1.2 Human Serum Albumin 
 Human serum albumin (HSA) is a carrier protein in 
homo sapiens. HSA is the most abundant protein found in 
blood plasma and has several significant physiological 
functions. These functions include the transport of fatty 
acids, hormones, amino acids and toxic metabolites as well 
as the regulation of oncotic pressure, which is the pressure 
proteins exert in a blood vessel pulling water into 
capillaries.[6] HSA is also responsible for the distribution of 
pharmaceutical drugs and other key analytes to the necessary 
organelles and tissues. Through this distribution process, 
upon ligand binding to HSA the pharmokinetic and 
pharmodynamic properties of the drugs may become altered. Thus, it is important to study 
interactions between this protein and ligands possessing therapeutic properties to gain insight on 
how binding to the different subdomains of HSA may influence this phenomenon.   
 
Figure 2. Human Serum 
Albumin Crystal Structure 
Image taken with 
permission from Dr. 
Andrew Hamilton on 
June 20, 2015[1]. Original 
crystal structure obtained 
from PDB (1ha2 ).	  
3	  
	  
1.2.1 Sudlow’s Binding Sites 
 Human Serum Albumin contains two prominent binding sites known as Sudlow’s Sites. 
These may be seen in Figure 2 labeled as Site I and Site II[1]. Site I is found in subdomain IIA of 
HSA. This site binds bulky heterocyclic anions with centrally located charge[7]. Pharmaceutical 
compounds such as Warfain and Azapropazone are known to bind to this site[6-7]. Site II is 
located in subdomain IIIA and tends to bind aromatic carboxylates with extended conformation. 
Site II is the most active and accommodating site of the two[7]. Ligands such as Ibuprofen bind to 
this site. Some therapeutic agents such as the thyroid hormone Thyroxine may bind to both of the 
Sudlow Sites due to allosteric effects of concurrent binding with other drugs or fatty acids[7].  
 HSA may undergo reversible conformational isomerization. Through pH- and allosteric- 
effectors, HSA conformation may change into various forms including fast (pH 2.7-4.3), neutral 
(pH 4.3-8.0) and basic (pH 8.0+). The fast form is characterized by decrease in alpha-helix 
content, the neutral maintains a heart-shape structure, while the basic form also has a decrease in 
alpha-helix with an increased ligand infinity. The conformational changes taking place in HSA 
during drug binding may change the pharmacological behavior of drugs bound to the protein[7].  
 Due to the large binding capacity of human serum albumin, the effect of binding multiple 
ligands simultaneously is difficult to study. Multiple compounds may be bound to the protein at 
one time, although the binding of one may affect the binding of another due to allosteric effects 
or conformational changes.  
 Through fluorescence spectroscopy, the HSA residue Trp-214 was used to observe 
conformational changes due to its fluorescence emission wavelength of 350 nm. By binding 
compounds to the protein, fluorescence analysis is an invaluable tool for the elucidation of 
protein behavior and mechanism of multidrug binding action.  
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1.3 Near Infrared Dyes 
1.3.1 Electromagnetic Spectrum 
 The electromagnetic spectrum is the 
foundation of spectrophotometry and the 
study of complex biomolecules. Molecules 
become excited by energy in the form of 
light, absorbing some of that energy at a 
specific wavelength, exciting electrons to a 
higher energy state, then falling back down 
at another wavelength. The wavelength and 
energy at which the electrons excite and emit are summarized by the electromagnetic spectrum. 
For the purpose of this investigation, the UV-visible-near infrared region (260-700 nm) will be 
discussed. As seen in Figure 3, the ultra-violet (UV) region spans roughly 250-400 nm, the 
visible region spans 400-700 nm and the near infrared region (NIR) spans 600-1200 nm. HSA 
absorbs in the UV region, MGF absorbs in the visible region and the dyes used as a probe for 
HSA binding absorb in the near infrared region.  
1.3.2 Chromophores 
 Fluorescence spectroscopy is one method used to investigate the spectral properties of 
near infrared dyes in binding investigations, specifically for biological applications. NIR dyes 
fluoresce approximately between 600-1200 nm[8]. Although biological molecules including 
proteins, DNA and hemoglobin are virtually non-fluorescent; their emission wavelength does not 
interfere with that of the dyes allowing the distinction between dye and macromolecule [8-9]. The 
NIR dyes are referred to as chromophores, due to their vibrant colors visible with the naked eye. 
Image taken without permission from 
CHANDRA.harvard.edu/ 
Figure 3. Electromagnetic Spectrum	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An example of this may be seen in Figure 4. The biological applications of the chromophores 
come specifically from their characteristic colors. These dyes are used as contrast agents during 
Computerized Tomography (CT), nuclear Magnetic Resonance Imaging (MRI) scans and also 
with newer healthcare instrumentation that utilize Raman Scattering during surgery. These dyes 
are used as an aide in diagnosis and a real time surgical guide.  
 It is believed that the dyes bind to HSA 
and are transported in the central circulatory 
system to target tissues and organelles, filtered 
out via the kidneys and thus excreted through 
urine. Dyes are currently being designed for the 
primary purposed of disease prevention and 
diagnosis. In our studies two dyes (E-06 and 
MHI-06) are currently investigated for how 
they influence the conformation of HSA when 
bound to the therapeutic agent mangiferin. 
Previous studies have revealed that both of the dyes and mangiferin bind to HSA, mangiferin in 
subdomain IIA and the dyes in subdomain IIIA[9-10]. The near infrared dyes will be used as a 
probe to study any conformational changes to HSA as a result of their addition to mangiferin 
bound protein. The Trp-214 residue will be examined because it is the binding site of mangiferin. 
Upon dye addition, any resulting spectral changes at this binding site may give insight as to the 
effect of the dye on protein conformation and the effect of mangiferin on the stability of protein 
conformation.  Through competitive binding of the dyes with mangiferin, the interaction between 
HSA, therapeutic agent and dye may be assessed.  
Image of myself working with dilutions of 
chromophore Fluorescein (on left), and 
non-chromophore HSA (on right).   
Figure 4.  Chromophore Visual	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1.3.3 Woodword-Fieser Rules and Conjugation 
 The most frequently used NIR dyes have absorption in the range between roughly 600-
1200 nm. The closer a wavelength maximum is to 400 nm or below is known as a hypsochromic 
shift or a blue shift. The closer a wavelength maximum is to 700 nm or beyond is known as a 
hypochromic shift or a red shift[11]. Each compound has an inherent absorbance and fluorescence 
maxima, though this may change due to solvent polarity or aggregation. Another way a 
compound may change its wavelength maxima is through extended conjugation, which in turn 
makes a new compound.  
 Conjugation from the presence of alternating double bonds is what gives a fluorophore 
(fluorescence compound) its fluorescence. The greater the conjugation the greater the red shift 
hence wavelength maxima. Theoretically, the conjugation of a compound may be calculated such 
that a compound with a specific absorbance wavelength may be synthesized. This may be done 
through the application of Woodword-Fieser rules. These rules give a rough estimation of where 
a compound will yield an absorption maximum based on its conjugation and substituents. These 
rules require the calculation of wavelength maximum for the base, which is the longest 
conjugated chain present and then additional nanometers are added based on attached 
substituents. These rules allow for the absorbance wavelength maximum estimate for conjugated 
diene correlations, α, β unsaturated carbonyl compounds or ketones and aromatic compounds. 
The rough estimation of the absorbance wavelength maximum based on conjugation is key to 
ensure there is no autofluorescence from biological molecules.  
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1.4 Jablonski Diagram 
 The Jablonski Diagram depicts the basic 
electronic transitions in Spectrophotometry. The 
energetically induced transitions described within 
include Absorption, Fluorescence, Intersystem crossing 
and Phosphorescence.  
1.4.1 Absorbance 
 Absorbance is the process of electron excitation 
from the ground singlet state to the Sn (n=2,3…) 
excited state. Electrons become excited by photons from a light source. Upon absorption, 
electrons undergo vibrational relaxation, where the electrons lose energy within own self-
molecule, down to the lowest vibrational level of their highest excited state. Once at the lowest 
energy of the excited state, internal conversion takes place. This is due to the excited singlet 
states being so close in energy and once internal conversion occurs, vibrational relaxation occurs 
down to the lowest energy in the first singlet excited state. From this lowest level back down to 
the ground state is known as fluorescence. 
 Absorbance of a sample is measured via the transmittance of a beam of light through the 
sample in a cuvette where the transmitted light is measured by a detector. From the 
transmittance, a spectrum of wavelength scanned vs. absorbance measured is produced. As seen 
in Equation 1, absorbance equals negative log base ten of transmittance. This is how the UV-VIS 
instrument converts the percent transmittance signal into the absorbance. During spectral 
analysis a calibration curve is produced to assess linearity of data obtained. This linearity range 
Diagram depicts basic electronic 
transitions in Spectrophotometry. 
Figure 5. Jablonski Diagram 
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is due to the Beer-Lambert range circa 0.1-1.0 absorbance units. The Beer-Lambert Law is 
expressed in Equation 2. 
A  = - log10T  (1) 
A = ε ι c  (2) 
 In this equation, the absorbance (A) is equal to molar attenuation coefficient (ε), cell path 
length (ι) and concentration (c). Each compound has a specific wavelength where maximum 
absorbance occurs and this is known as absorbance maximum (λmax). The absorbance is not 
necessarily compound specific, as multiple compounds can have absorbance in similar or even 
the same region. Though, the molar attenuation coefficient is inherent to each individual 
compound making it compound specific. The ε expresses how strongly a compound attenuates 
light at a given wavelength. This value may be obtained from the slope of a calibration curve, as 
a calibration curve plots concentration against absorbance. Though, the cell path length is 
typically 1 cm, this may change based on what diameter cuvette is used and should be taken into 
consideration for calculation. As the absorbance examines the excitation of a sample, the 
fluorescence examines the emission of the sample. 
1.4.2 Fluorescence 
 Fluorescence occurs from the lowest vibrational level in the excited singlet state down to 
the ground singlet state. During this transition, several routes may lead to dispersion or loss of 
energy from the target molecule. A molecule can have a decrease in fluorescence known as 
quenching due to interactions with itself (dynamic/collisional quenching), interactions with other 
molecules (static quenching) or via photon loss. This utility of analyzing this transition is the 
focus of this research. 
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 As previously mentioned, the linearity range for absorbance analysis should fall between 
0.1-1.0 absorbance units. Although, for samples, which require fluorescence measurements, the 
linearity range falls between 0.05-0.1 absorbance units, as the fluorescence instrumentation is 
highly sensitive. This required sensitivity is due to the Inner 
Filter Effect (IFE). As seen in Figure 6, excitation occurs at a 
90° angle from emission detection in a spectrophotometer. A 
light source emits a beam that penetrates the sample cuvette 
causing the excitation of the sample, leading to its 
fluorescence and measurement by the detector.  
 The IFE occurs when a sample is too concentrated and 
the excitation beam causes sample attenuation at the wall of the cuvette, in turn resulting in an 
uneven distribution of fluorescence and therefore distorted spectra is observed. By diluting a 
sample to a lower concentration with absorbance below 0.1-0.5 absorbance units, also depending 
on the sensitivity of the instrument, the sample fluorescence will occur evenly distributed 
throughout fluorescence cuvette resulting in an undistorted spectra. 
 Several other sources may be the cause of spectral distortion. In order to rule out 
instrumental issues prior to fluorescence measurements, a Raman peak validation should be run. 
During this validation, DI water is placed into a cuvette and validation is run with excitation 
parameters set by the user[12]. The utility of using DI water for validation includes the lack of 
toxic chemicals, waste, accessibility and reliability. The input excitations may vary using the 
same or different instruments as the energy between the excitation and Raman peak will be 
equivalent, universally producing a reliable validation peak[12].  
Figure 6. Inner Filter Effect 
Evenly distributed 
fluorescence (left) and 
attenuation of fluorescence 
leading to distorted spectra 
(right). 
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 This process examines the width, height and relative location of the Raman peak. In 
doing so, the signal to noise ratio is calculated and reported. If the report indicates a failure of 
this validation, the most likely errors are the instrument did not have sufficient time to warm up 
or the light source requires replacement. A passed validation is vital to obtaining fluorescence 
spectra.  
 Intersystem crossing and phosphorescence will be outlined briefly as they are not 
examined in this research. Intersystem crossing occurs from the lowest vibrational level of the 
singlet excited state to an equivalent energy level in the triplet excited state. The single excited 
state refers to an anti-parallel electron that has become excited into a higher energy state. When 
the electron remains anti-parallel it satisfies the Pauli Exclusion Principle which states that 
electrons fill their orbitals beginning with the lowest energy and the electrons are paired in anti-
parallel fashion. During intersystem crossing, an electron transitions from the singlet-excited 
state to the triplet-excited state undergoing a spin forbidden transition and becomes parallel. The 
procession of this electron back down to its anti-parallel orientation and back down to the ground 
state takes time and fluoresces at a slower rate. This is known as phosphorescence.  
1.5 Molecular Modeling 
 Molecular modeling is a technique used to aid in investigations of chemical species by 
observing molecular dynamics in specified environments. The environment surrounding a 
molecule of interest can be manipulated in a variety of ways to suggest basic behavior that may 
be applicable to dynamic systems. For instance, temperature, solvent, molecules interacting with 
one another and adding specific constrains are a few of the ways a molecule can be observed to 
gather insight on basic molecular dynamics. Simulations and calculations may be obtained for 
insight on the basic interactions of a molecule. This technique is a preliminary technique used to 
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suggest simplified models of real dynamic systems. Molecular modeling programs use a semi-
empirical approach to data gathering. The semi-empirical approach uses data that has been 
previously tested hands on and combines that with algorithms to calculate probable 
thermodynamic constants. This approach can only give preliminary suggestions as to chemical 
dynamics and is not representative of dynamic in vivo systems.  
1.6 Aim of Investigation 
 Mangiferin is a natural compound currently being studied for its various health 
benefits[13]. This polyphenol is distributed throughout the blood via the carrier protein human 
serum albumin. In order to gain insight on any possible changes in the pharmokinetic and 
pharmodynamic properties of the mangiferin-human serum albumin binding interaction, the 
fluorescence Trp-214 residue in HSA will be studied using fluorescence spectrophotometry. The 
effect of the mangiferin on the Trp-214 fluorescence will initially be studied, followed by the 
addition of NIR dyes to examine if there is any change in Trp-214 spectra upon competitive 
binding. By competitively binding the NIR dyes to the HSA, the protein may change 
conformation, potentially causing a change in affinity for either the dye or mangiferin therefore 
potentially changing distribution and efficacy of the polyphenol.  
 The human serum albumin and mangiferin binding interaction will be examined using 
absorbance, fluorescence, molecular modeling and competitive binding techniques. 
 
2 EXPERIMENTAL 
 
2.1 Reagents 
 Sodium phosphate dibasic anhydrous, free-flowing, Redi-Dri™, ACS reagent, ≥99% 
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(CAS 7558-79-4) and sodium phosphate monobasic monohydrate, ACS reagent, ≥98% 
purchased from Sigma-Aldrich, Saint Louis, MO 63103, USA (CAS 10049-21-5).  Mangiferin 
from Mangifera indica bark (CAS 4773-96-0), Albumin, from human serum, lyophilized powder 
>97% (agarose gel electrophoresis) obtained from Sigma-Aldrich, Saint Louis, MO 63103, USA 
(CAS 70024-90-7). Near Infrared region dyes MHI-06 and E-06 synthesized in house by Eric 
Owens under the advisement of Dr. Maged Henary. HPLC grade methanol >99.9% obtained 
from Sigma-Aldrich, Saint Louis, MO 63103, USA (CAS  200-659-6). 
 
2.2 Sample Preparation 
 Phosphate saline buffer solution was prepared by following FDA laboratory method 
guidelines. One liter of 0.2 M monobasic phosphate solution is prepared by dissolving sodium 
phosphate monobasic monohydrate into triple distilled water. One liter of 0.2M dibasic 
phosphate solutions is prepared by sodium phosphate dibasic anhydrous into triple distilled 
water. A final 0.02 M PBS is prepared by mixing a dilute monobasic and dibasic solution to 1:10 
with DI water. The buffer is adjusted to pH 7.31-7.41.  All further dilutions use this pre-made 
buffer.  
 Human serum albumin (HSA) solution is prepared in PBS 0.02 M to a stock 
concentration of 1x 10-3M. Mangiferin stock solution is prepared in PBS to a concentration of 1x 
10-4 M and sonicated for 10 minutes until all particulates have dissolved in full. Dyes MHI-06 
and E-06 were previously prepared in HPLC grade methanol to a concentration of 1x 10-3 M and 
sonicated for 10 minutes following further sample preparation. During sample preparation, 
samples in which dyes are present contain methanol content remaining constant at 1.4%. HSA is 
initial constituent added to solution where as methanol is added last in order to prevent HSA 
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denaturing.  
 
2.3 Instrumentation 
 Buffer is adjusted using Schott pH electrode BlueLine and Thermo Orion VWR sb20 
Symphony pH meter. Triple distilled water obtained from Georgia State University Core 
Facilities.  
 Absorbance spectra obtained from Cary WinUV (Santa Clara, CA, 95051), using Cary 
WinUV software. Absorbance also obtained from Perkin Elmer Lambda 25, (Waltham, 
Massachusetts 02451) using UV Winlab software. Fluorescence spectra obtained from Perkin 
Elmer Fluorescence Spectrophotometer LS-55 (Waltham, Massachusetts 02451) using FL 
Winlab software.  
  
2.4 Molecular Modeling 
 Molecular modeling performed using WaveFunction Spartan 14 and HyperChem 
Professional 8.0 software. Docking investigation completed using AutoDock 4.2 and 
Visualization Molecular Docking v1.9.1 (VMD). 
 
3   RESULTS AND DISCUSSION 
3.1 Absorbance 
 Human serum albumin (HSA) solutions are prepared in 0.02M PBS. Initially, HSA 
behavior was analyzed via UV-Vis at 10%, 50% and 90% HSA in PBS. Figure 7 shows 
representative spectra. Since, 10% HSA in PBS falls into the Beer-Lambert linearity range of 
absorbance, this is the maximum percentage of HSA used for the absorbance investigation of 
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HSA-mangiferin binding. HSA-mangiferin samples were prepared with a constant 50 µL volume 
of HSA (10% HSA) and incrementally increasing volume of mangiferin from 0-110 µL 
increasing by 10 µL. Buffer added to adjust total final volume up to 5 mL.  
 Figure 8 shows the resulting absorbance spectra for human serum albumin binding to 
mangiferin. The absorbance maximum of Trp-214 is 282 nm and 383 nm for mangiferin. 
Mangiferin absorbance shows an increasing linear trend upon increase of concentration. The 
Trp-214 experiences an increase in absorbance and a slight blue shift from 282 nm to 263 nm 
upon binding. The inset in Figure 8 indicates that the mangiferin absorbance overlaps with the 
Trp-214 causing an increase in absorbance. The phenomena of a blue shift is suggested to occur 
due to the peptide strand extension occurring in HSA as reported by Yuanyuan Yue, et.al [14]. 
The linearity of the trend is observed through a calibration curve in Figure 9 with a R2 value of 
0.99877. 
 
Figure 7. HSA Absorbance Investigation 
 
HSA prepared in 0.02M PBS pH 7.4 at 10%, 50% and 90%. Spectra run on Cary WinUV using 
Cary Win software. Spectra obtained using a quartz cuvette.  Scan range 250-350 nm. SBW 5 
nm. Scan speed 150 nm/min. HSA λmax=280 nm.  
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Figure 8. Trp-214 Mangiferin Absorbance 
 
Solution prepared in 0.02M PBS pH 7.4 with 10% HSA. Magiferin volume is increasing from 0-
110 µL (a-l). Graphical inset shows the absorbance of 110 uL of Mangiferin in PBS with no 
HSA. Spectra run on Cary WinUV using Cary Win software. Spectra obtained using a quartz 
cuvette. Scan range 250-450 nm. SBW 5 nm. Scan speed 150 nm/min. Trp-214 λmax=282-263 
nm. Mangiferin λmax=383 nm. 
 
 
Figure 9. Mangiferin Calibration Curve 
 
Calibration curve is plotting mangiferin concentration (M) vs. mangiferin absorbance from 
spectra found in Figure 12. Linearity of R2=0.99877. 
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3.2 Fluorescence 
 For fluorescence analysis, the Perkin Elmer LS-55 instrument is utilized. HSA-
mangiferin samples were prepared with a constant 3500 uL volume of HSA and incrementally 
increasing volume of mangiferin from 0-110 uL, increasing in 10 uL increments. Buffer added to 
adjust total final volume up to 5 mL. Figure 10 shows the fluorescence spectra for Trp-214-
mangiferin binding.  The spectral behavior of Trp-214 indicates a binding event between itself 
mangiferin. The calibration curve shown Figure 11 suggests a linear fluorescence response from 
the Trp-214 upon increasing the concentration of mangiferin. Previous literature has suggested 
mangiferin’s propensity for binding with HSA in the hydrophobic binding pocket of subdomain 
IIA, where the sole tryptophan residue resides (Trp-214). This residue is majorly responsible for 
the fluorescence of HSA and is also a dominant residue in drug binding. The Trp-214 residue 
fluoresces at 349 nm in PBS. Upon the addition of the mangiferin to the HSA, the fluorescence 
decreased. This observed effect is proposed to be quenching of the Trp-214 residue by the MGF. 
In the Trp-214 MGF spectra, an isosbestic point appears to be forming around 430 nm, although 
the increase in fluorescence is due to the second order peak at 520 nm, as a result of the Rayleigh 
Peak at the excitation wavelength of 260 nm. Extending the spectra farther, the third order peak 
is also visible at 680 nm. 
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Figure 10. Trp-214-Mangiferin Binding Fluorescence Spectra 
 
(a) Constant concentration of human serum albumin (7.5 uM) is titrated with an increasing 
concentration of mangiferin a-l (0-110 uM). Trp-214 emission maximum is 349 nm. Shoulder 
peaks are labeled as 1, 2 and 3. (b) Mangiferin fluorescence at concentrations of 10 µM, 50 µM 
and 110 µM, without the presence of albumin. Mangiferin emission maximum is at 309 nm. 
Solvent is PBS with a pH of 7.4. Spectra obtained via Perkin Elmer LS-55, excitation 
wavelength 260 nm, 5 SBW, 150 nm/s. 
 
 Figure 10 is the representative spectra for Trp-214 binding to mangiferin. Three shoulder 
peaks are present in addition to the maximum emission wavelength, which is due to Trp-214. 
Peak 1 seen on the far left is due to overlapping mangiferin fluorescence. The inset in Figure 10 
shows the fluorescence of manigferin at 10 µM, 50 µM and 110 µM. Mangiferin appears to be 
self-quenching as shown by the inset and also visible by the gradual disappearance of the peak 
on the Trp-214 spectra. Though, two other peaks are present, peak 2 and peak 3. In order to 
further investigate the nature of these peaks, basic manual peak deconvolution was performed. 
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Figure 11. Calibration Curve for Trp-214 Fluorescence 
 
The calibration curve for the Trp-214 mangiferin binding shows a linear decrease in fluorescence 
with a R2 = 0.99323. Concentration is on the x-axis and fluorescence intensity is on the y-axis. 
 
Figure 12. Deconvolution of Trp-214 Spectral Shoulder Peaks 
 
Calibration curve plots the ratio of shoulder to Trp-214 fluorescence intensity vs concentration of 
Mangiferin (0-110 uM). Right shoulder, left shoulder and far left shoulder emission maximums 
are as follows 373 nm, 331 nm and 309 nm.  
 As seen in Figure 12, peak deconvolution isolates the three peaks of interest by plotting 
the concentration of mangiferin to the ratio of the shoulder peaks fluorescence to Trp-214 
fluorescence. This figure shows strong linearity between each of the peaks, suggesting that the 
shoulder peaks are consistently part of the binding event and not randomly occurring events. The 
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shoulder peaks were initially believed to possibly be due to the phenylalanine and tyrosine 
residues in the human serum albumin protein, although were discounted due the their weak 
fluorescence and that their fluorescence wavelengths do not coincide with that of the shoulder 
peaks. The occurrence of shoulder peaks is believed to be due to conformational change within 
the protein itself. Obaidur Rahaman et al. investigated the unfolding pathways of human serum 
albumin and found that under varying pH, solvent or even binding conditions, slight shoulder 
peaks may be found in fluorescence spectra which are indicative of protein unfolding[15]. 
Table 1. Detection and Quantification Analysis 
 MGF 
Ka 0.15 E 5 M-1 
LOD (6-12 uM) 0.424 
LOQ (6-12 uM) 1.29 
%RSD (6-12 uM) 
1.49 
% Error 0.61 
Table 1 presents the associative binding constant, limit of detection, limit of quantification, 
percent relative deviation and percent error of fluorescence data for binding between HSA and 
mangiferin between the concentrations of 6-12 µM of mangiferin. 
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Figure 13. Stern Volmer Plot  
 
Stern Volmer Plot of the binding between HSA and mangiferin shows an upward curvature, 
which is indicative of cooperative binding between the two species.  
 
 Table 1 presents the calculated binding constant, limit of detection (LOD), limit of 
quantification (LOQ), percent relative standard deviation (% RSD) and percent error. The LOD 
and LOQ are both below 2.0 suggesting that quantification of HSA binding to 6-12 µM of 
mangiferin is accurate and precise. 
 The upward curvature of the Stern Volmer analysis in Figure 13 suggests a possible 
combination of static and dynamic quenching. Quenching is the term used to describe any 
process that results in decreased fluorescence intensity of a sample[11]. Static quenching refers to 
the formation of a non-fluorescent ground state complex between a fluorophore and quencher. 
Dynamic quenching, also known as collisional quenching, occurs when a fluorophore and a 
quencher have a collisional encounter during the excited lifetime of the fluorophore. Upon 
contact, the fluorophore returns to ground state without photon emission[11]. Analysis by the 
Scatchard Plot (Double Reciprocal Plot), as seen in Figure 14, resulting in the associative 
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binding constant of Ka = 0.15 x 105 M-1, which agrees reasonably to previously obtained 
literature value of 0.33 x 105 M-1[14, 16]. Initially, the goal was to determine whether the 
quenching of the Trp-214 residue was static or dynamic through Kapparent calculations from linear 
regression analysis (Figure 15).  The suggested combined quenching by the Stern Volmer Plot in 
Figure 13 is found to be unlikely upon further analysis. Equation 3 found below is the Stern 
Volmer Equation[17]. The variables are filled in with the slope  (KS*KD) and y-intercept (KS + 
KD) from Kapp plot and then the apparent binding constant is solved by using the quadratic 
equation. The values could not be obtained, for calculations resulted in an imaginary number. 
This result suggests combined quenching is not occurring. Upon further investigation, proof has 
also been presented through the analysis of HSA and MGF through Method of Continuous 
Variation, also known as the Jobs Method for Determining Binding Stoichiometry.  
Figure 14. Scatchard Plot  
 
The binding constant is determines by plotting the inverse of quencher concentration 
(mangiferin) by the inverse of change in fluorescence. Dividing the y-intercept by the slope 
results in the associative binding constant Ka = 0.15 x 105 M-1. 
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Figure 15. Kapparent Binding Constant Determination 
 
K apparent binding constant determination is performed by plotting the quencher concentration 
(mangiferin) vs. the Kapp term that represents ((Fo/F-1)/[Q]), initial fluorescence, divided by 
final fluorescence minus 1 divided by quencher concentration.  
 
Fo/F = 1 + Ksv[Q] (3) 
 
 As seen in Figure 16, a peak forms at the top of the graph. A line can be drawn on the 
data points to the left and right of this apex. An arrow is drawn downward toward the x-axis 
from the point where these lines intersect. This tip of the arrow points to the stoichiometric ratio 
of binding. During the Method of Continuous Variation, the concentration of both components 
remains constant, but the mol ratio of one compound decreases as the other increases. The arrow 
in Figure 16 points to roughly 0.600 mol fraction, which is indicative of a 2:1 binding ratio of 
mangiferin to HSA.  
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Figure 16. Method of Continuous Variation  
 
The graph plots mol fraction of mangiferin in the solution vs. absorbance. The point of 
intersection at the apex results in stoichiometric mol fraction of the mangiferin to the HSA. The 
point of intersection results in roughly 0.600 mol fraction. 
 
 Through Jobs analysis, the MGF binds to HSA with a 2:1 stoichiometry. Due to this 2:1 
binding there are multiple binding events, although they may not take place with the same 
residue. Due to this, the Kapp cannot be calculated using fluorescence spectra alone and takes 
more advanced methods for determination of the second possible binding residue. These results 
suggest a cooperative binding event where multiple mangiferin ligands bind to multiple residues 
within human serum albumin. Determined binding stoichiometry was applied during the 
competitive binding analysis.  
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4    MOLECULAR MODELING 
4.1 Molecular Docking 
 Molecular modeling software was used in order to visualize mangiferin followed by a 
docking study in order to observe binding interaction of mangiferin with human serum albumin. 
Initially, mangiferin was modeled using HyperChem software, then input in AutoDock 4.2 as a 
ligand. Human serum albumin crystal structure was retrieved from protein data bank (1H9Z). 
Macromolecule (HSA) was set as rigid and ligand glycosidic bond was rotatable. Upon ligand 
docking with macromolecule, resulting docking (Figure 17) shows the lowest obtained Gibbs 
free energy upon binding to Trp-214 residue. Further examination via enlargement of grid box 
also presented a low Gibbs free energy with Tyr-401 residue, suggesting mangiferin may also 
bind to this residue. Considering the 2:1 binding stoichiometry between mangiferin and HSA, 
there is a possibility that mangiferin can bind to both the Trp-214 and Tyr-401 residues 
simultaneously, which would support the cooperative binding proposition.  
Figure 17. Molecular Docking of Mangiferin with Human Serum Albumin 
 
HSA receptor obtained from protein data bank (1H9Z). VMD used to create model and 
Autodock used for molecular docking of mangiferin to human serum albumin. Orange residue is 
that of Trp-214. MGF ligand is 3.91 angstrom from receptor.  
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5    CONFORMATIONAL CHANGES IN HUMAN SERUM ABLUMIN MONITORED VIA 
TRP-214 RESIDUE UPON MANGIFERIN AND NIR DYE BINDING 
 
5.1 Effect of E-06 on Trp-214 Fluorescence 
 Near infrared dyes are examined for their utility in biological applications. Several in vivo 
applications exist in the medical field, such as real time scans including computerized 
tomography (CT), nuclear Magnetic Resonance Imaging (MRI) and laser guided surgery. Due to 
the importance of these medical procedures and the utility of using dyes to assist with them, they 
are currently being investigated as to their influence upon binding to human serum albumin and 
their affect on mangiferin. Previously reported data have revealed that the dyes studied are 
believed to bind to subdomain IIIA (Suldow’s Site II). Although the dyes do not bind to the same 
subdomain as mangiferin (subdomain IIA), they may still play a vital role in the conformational 
changes of HSA. The binding of the dye may elicit a response from the HSA that may affect its 
binding interaction with mangiferin.  
 Due to the beneficial properties of mangiferin and its binding to subdomain IIA, protein 
interactions are examined at its binding site, the Trp-214 residue. Initially the effect of E-06 on 
Trp-214 is examined via a serial dilution of the dye, followed by competitive binding between E-
06 and ibuprofen, both which bind to subdomain IIIA. This spectral analysis was used to 
compare the effect of mangiferin on Trp-214 versus the dye alone.  
 In Figure 18, three sets of samples are present, on the left the magenta (E-06), in the 
middle the turquoise (MHI-06) and on the right the colorless (Ibuprofen).  The Ibuprofen is used 
as a competitive binding agent against the E-06, for both are suggested to bind to the same 
subdomain. The spectral differences between binding two agents to the same subdomain and 
binding two agents to differing subdomains are analyzed. All four of these agents, including 
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mangiferin, are used as probes to analyze any conformational changes exhibited through the 
fluorescence of Trp-214. 
Figure 18. Probing Agent Solutions 
The probing agents include the two NIR dyes E-06 (magenta) and MHI-06 (turquoise) as well as 
Ibuprofen (colorless). Concentrations of 1x10-4 M, 1x10-5 M and 1x10-6 M. Solvent in use is 0.2 
M PBS, pH 7.39-7.4 for the Ibuprofen. Methanol is solvent for E-06 and MHI-06. 
 
 Initially, the absorbance of the dyes is observed. Both dyes are 1 x 10-6 M in 
concentration and the molar attenuation coefficient of MHI-06 is 116,000 M-1cm-1 and E-06 is 
106,900 M-1cm-1[9]. The MHI-06 peak distortion in comparison to that of E-06 is due to PBS 
solvent. The MHI-06 is susceptible to changes in polar conditions, therefore resulting in the peak 
found in Figure 19[9]. The absorbance maximum for E-06 and MHI-06 is 544 nm and 759 nm 
and the emission maximum is 782 nm and 759 nm, respectively. Neither of these emission 
wavelengths interferes with that of Trp-214 (349 nm), therefore making them suitable for 
binding analysis. 
 Figure 20 displays the effect of E-06 serial dilution on the fluorescence intensity of Trp-
214. For the serial dilution trial the HSA concentration was held constant at 20 µL, prepared 
from a 1x10-4 M stock solution. The E-06 concentration ranged from 10-110 µL. Due to dye 
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stock solution preparation in methanol, methanol concentration was constant at 1.4 % in all 
trials. Each trial was performed in triplicate. Samples consisting of HSA and E-06 alone were 
also obtained for comparison.  
 As seen in Figure 20, the fluorescence of the dye is negligible in comparison to the HSA, 
which fluorescence around 550 intensity units. The increase in concentration of E-06 does not 
result in any linear response and instead results in a broad distribution of Trp-214 fluorescence. 
There is no clear correlation between Trp-214 fluorescence upon the addition of E-06. The mean 
and standard deviation of these trials are summarized below in comparison to the other trials in 
Table 2.  
 
Figure 19. E-06 and MHI-06 Absorbance 
 
Spectra obtained via CaryWinUV. Solvent is PBS pH 7.4.  Both solutions are 1 x 10-6 M. Both 
stock solutions prepared in 10% methanol. SBW 2 nm, scan speed 240 nm/min. 
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Figure 20. Effect of E-06 Serial Dilution on Fluorescence Intensity of Trp-214  
 
Serial dilution of E-06 ranges from 10-110uL. HSA is constant volume of 20 uL. Trp-214 λem= 
349nm. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm SBW 5nm. Scan speed 150 
nm/min. Perkin Elmer LS-55. Scan range 280-460nm. E-06 structure on left. 
 
 Due to the nature of the E-06 Trp-214 fluorescence spectra, Figure 21 is a visual aide to 
observe the changes in fluorescence intensity of Trp-214. As mentioned, there is no linearity in 
the fluorescence response. Qualitative analysis suggests that the Trp-214 residue is sensitive to 
changes in E-06 concentration and does not react in a predictable fashion upon its binding. This 
suggests the HSA conformation is sensitive to E-06 concentrations upon binding and although 
the dye is suggested to bind in subdomain IIIA, the binding event influences subdomain IIA is 
depicted in Trp-214 fluorescence spectra. 
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Figure 21. Graphical Representation of Changes in Trp-214 Fluorescence Intensity Upon Serial 
Dilution of E-06 
 
Serial dilution of E-06 10-110uL. HSA constant volume of 20 uL. TRP-214 λem= 349nm. 
Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm SBW 5nm. Scan speed 150 nm/min. 
Perkin Elmer LS-55. Scan range 280-460nm. 
 
 Probing of Trp-214 is currently conducted through a secondary site subdomain IIIA 
rather than the primary site of interest, subdomain IIA. Examining the Trp-214 residue under 
various conditions may give insight as to the influence of the one subdomain on the other during 
a binding event. Considering the apparent random intensity fluctuations in Trp-214 fluorescence 
spectra upon E-06 binding, competition between E-06 and Ibuprofen was performed to 
investigate whether this event would produce the same or different spectral results. 
 Spectra of E-06, Ibuprofen and HSA are individually obtained, followed by E-06 with 
Ibuprofen and HSA, E-06 and Ibuprofen in a 1:1:1 stoichiometric ratio.  Each following sample 
contains 25-50 µL of Ibuprofen with 20 µL HSA and 20 µL E-06. Resulting spectra in Figure 22 
is also non-linear though the distribution is less spread out than previously with E-06 and HSA 
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alone. Note that upon the addition of Ibuprofen to the dye, there is an increase in overall 
fluorescence intensity.  The statistical spread of this data may also be found in Table 2. A 
graphical aide to visualize this non-linear data may be found in Figure 23. The highest 
fluorescence intensity results from the 1:1:1 HSA, E-06 and Ibuprofen sample. Trp-214 by itself 
has the highest fluorescence of these samples suggesting that the tryptophan residue is most 
exposed and upon addition of the dye and Ibuprofen the fluorescence decreased through 
conformational change in the protein.  
 
Figure 22. Effect of E-06 and Ibuprofen Competitive Binding on Trp-214 Fluorescence 
 
HSA and E-06 have constant volume of 20 uL. Ibuprofen volume is 20-50 uL. Trp-214 λem= 
349 nm. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm SBW 5nm. Scan speed 150 
nm/min. Perkin Elmer LS-55. Scan range 280-460nm. E-06 structure found on left and Ibuprofen 
on right.  
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Figure 23. Effect of Competitive Binding on Fluorescence Intensity of Trp-214 
 
HSA and E-06 have constant volume of 20 uL. Ibuprofen volume is 20-50 uL. Trp-214 λem= 
349 nm. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm SBW 5nm. Scan speed 150 
nm/min. Perkin Elmer LS-55. Scan range 280-460nm. 
 
5.2 Effect of E-06 and MHI-06 on Mangiferin-Trp-214 Fluorescence 
 Investigation of effect of NIR on mangiferin binding to Trp-214 began with E-06. The 
HSA concentration remained the same, 20 µL prepared from a 1x10-4M stock solution. 
Throughout the mangiferin-dye investigation, mangiferin concentrations remained constant with 
a 2:1 stoichiometric ratio to HSA, as determined previously via Jobs Plot. The concentration of 
E-06 increased from 40-70 µL. Fluorescence of mangiferin, E-06 and mangiferin with E-06 
solutions possess insignificant fluorescence with respect to that of HSA. Upon addition of E-06 
to the mangiferin bound Trp-214 mangiferin, the fluorescence intensity resulted in minimal 
fluctuation, as seen in Figure 24. Although, there is no linear response, the response appears 
within the same region. Statistical analysis results in acceptable percent relative standard 
deviation of data. This suggests the binding of E-06 has minimal effect on mangiferin binding to 
Trp-214. Figure 25 is the visual representation of the fluorescence fluctuations. 
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Figure 24. Effect of E-06 Concentration on Mangiferin Bound Trp-214 Residue  
 
HSA volume constant at 20 µL. MGF volume constant at 40 µL. HSA λem= 349 nm. E-06 
volume increases from 40-70 µL. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm 
SBW 5nm. Scan speed 150 nm/min. Perkin Elmer LS-55. Scan range 280-460nm. E-06 structure 
found on left and mangiferin structure on right.  
 
 Examination of Trp-214-mangiferin bound to MHI-06 using same procedure resulted in 
similar results. Figure 26 also depicts a non-linear fluorescence response, though minimally 
changing as to suggest lack of MHI-06 influence on Trp-214 residue when bound to mangiferin. 
Figure 27 graphically displays MHI-06 effect on Trp-214-mangiferin binding fluorescence. 
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Figure 25. Effect of E-06 Addition to Mangiferin Bound Trp-214 
 
HSA volume is constant at 20 µL. MGF volume is constant at 40 µL. HSA λem= 349 nm. E-06 
volume increases from 40-70 µL. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm 
SBW 5nm. Scan speed 150 nm/min. Perkin Elmer LS-55. Scan range 280-460nm. 
 
Figure 26.  Effect of MHI-06 Concentration on Mangiferin Bound Trp-214 Residue 
 
HSA volume constant at 20 µL. MGF volume constant at 40 µL. HSA λem= 349 nm. MHI-06 
volume increases from 40-70 µL. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm 
SBW 5nm. Scan speed 150 nm/min. Perkin Elmer LS-55. Scan range 280-460nm. MHI-06 
structure found on right and mangiferin structure on left.  
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Figure 27. Effect of MHI-06 Addition to Mangiferin Bound Trp-214 
 
HSA volume constant at 20 µL. MGF volume constant at 40 µL. HSA λem= 349 nm. MHI-06 
volume increases from 40-70 µL. Solvent used is 0.2M PBS with pH of 7.39-7.4. λex= 260nm 
SBW 5nm. Scan speed 150 nm/min. Perkin Elmer LS-55. Scan range 280-460nm. 
 
5.3 SUMMARY OF NIR DYE AFFECT ON TRP-214 FLUORESCENCE SPECTRA 
Table 2. Statistical Summary of Conformational Changes in Trp-214 Fluorescence 
 Trial Mean Variance SD % RSD 
Serial Dilution E-06 563.9 11153.7 10521 18.7 
Competitive Binding of E-06 with 
Ibuprofen 
308.0 1046.0 31.6 10.3 
Mangiferin Binding with E-06 429.1 40.9 6.4 1.5 
Mangiferin Binding with MHI-06 473.5 165.1 12.8 2.7 
All calculations preformed on fluorescence spectral values at maximum emission of 349 nm. All 
experiments performed in triplicate. Values obtained from average of triplicate trials. From left 
to right are the trials, mean, variance, standard deviation and percent relative standard deviation.  
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 Table 2 summarizes statistical calculations of fluorescence fluctuations at Trp-214 
emission maximum 349 nm.  All four trials were performed in triplicate and table represents 
averages of these data. The mean, variance, standard deviation (SD) and percent relative standard 
deviation (% RSD) are displayed. These data were calculated only using comparable samples. 
Reference samples such as HSA, mangiferin or dye alone were not used in calculations. The 
most important and revealing portion of this table highlighted in a black box is the % RSD. The 
serial dilution of E-06 and the competitive binding of the Ibuprofen with E-06 yield large % RSD 
values quantitatively suggesting the large spread in fluorescence intensities. The mangiferin 
binding with the E-06 and the MHI-06 result in low % RSD values, roughly >3% suggesting low 
spread of fluorescence intensities and also the accuracy and precision of this method for 
quantification purposes.  
Table 3. Association Constants for Probing Agents with HSA 
Probing	  Agent	   Ka	  x	  105	  M-­‐1	   	  
MGF	   0.15	   	  
E-­‐06*	   8.74	   	  
MHI-­‐06*	   10.6	   	  
Ibuprofen**	   1.2	   	  
*[9],**[18]	  Previously	  reported	  in	  literature.	  
Association constants are present for mangiferin (MGF), E-06, MHI-06 and Ibuprofen. Those 
probing agents with a star were previously reported in literature. The mangiferin constant was 
calculated from experimental data. 
  
 The association constants for the human serum albumin probing agents are listed in Table 
3. Fluorescence analysis revealed upon the binding of mangiferin to HSA, the addition of 
probing agents E-06 and MHI-06 resulted in no statistical change in fluorescence intensity. This 
suggests that although the association constant for mangiferin is lower than the other probing 
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agents, mangiferin and HSA form a stable complex that is not altered by the addition of E-06 or 
MHI-06. Though, the binding of mangiferin to the HSA protein appears to have a profound 
effect on the dye binding. Further investigations must be conducted in order to draw conclusions 
of behavior in subdomain IIIA. 
6    CONCLUSION 
6.1 Proposed Binding Domain Behavior and Mechanism 
 Mangiferin binds to human serum albumin in subdomain IIA. The ligand is proposed to 
bind to residues Trp-214 and possibly Tyr-401. Binding stoichiometry was found to be 2:1 to 
HSA. Stern Volmer and Kapparent analysis suggest cooperative binding between mangiferin and 
the albumin. Fluorescence analysis suggests hydrogen bond stabilization of the mangiferin 
molecule in the hydrophobic binding pocket. Addition of a probing agent that binds to 
subdomain IIIA causes non-linear changes in fluorescence intensity. Although, addition of 
mangiferin, which binds to subdomain IIA, followed by addition of E-06 or MHI-06, which bind 
to subdomain IIIA, results in no statistically different fluorescence intensity. This suggests the 
binding of mangiferin to HSA at a 2:1 ratio according to binding stoichiometry, results in a 
stable conformation of protein regardless of dye concentration.  
 The mangiferin binding interactions may be further elucidated by examination via 
circular dichrosim (CD). Through CD the protein binding interactions may be investigated by 
thermodynamic analysis. The 2-D nuclear magnetic resonance (NMR) technique of Nuclear 
Overhouser effect spectroscopy (NOESY) NMR can be used to determine hydrogen location 
through space in order to determine protein conformation. Crystal structure x-ray diffraction of 
mangiferin bound to HSA is also recommended. Considering the multiple health benefits of the 
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polyphenol mangiferin and therapeutic potential, the binding interactions between itself and 
human serum albumin are important to study. The possible interactions between mangiferin and 
other near infrared dyes are also important to study in order understand the possible effects one 
may have on the other. Through this research the pharmokinetic and pharmodynamic properties 
behind mangiferin-HSA binding may be understood and applied to pharmaceutical design.  
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